Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
octreotide 3-month extended release (Debio 4126)
i
Other names:
Debio 4126
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Debiopharm
Drug class:
SSTR agonist
Related drugs:
‹
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
pasireotide (1)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
pasireotide (1)
DG3173 (1)
octreotide extended release (0)
octreotide acetate (0)
vapreotide (0)
pasireotide long acting release (0)
octreotide acetate solution for injection (0)
CAM2029 (0)
MTD201 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login